top
Search terms
Results 1 - 9 of 9 - ordered by :
Epeuropace

Treatments with angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, statins, and omega-3 fatty acids all seem promising, over and above any effect related to the treatment of ...

Europace, ATRIAL FIBRILLATION, Irina Savelieva, John Camm

Date : 01/06/2008 Item size : 547475 bytes
Epeuropace

The economic burden of AF has grown in the past decades and is expected to rise further as the trend in AF prevalence and hospitalizations increases. [...]an adequate treatment strategy for AF is ...

Europace, CLINICAL RESEARCH, Nicola Bottoni, Massimo Tritto, Renato Ricci, Michele Accogli, Matteo Di Biase, Saverio Iacopino, Matteo Iori, Sakis Themistoclakis, Nadir Sitta, Gianmario Spadacini, ...

Date : 01/08/2010 Item size : 245434 bytes
Epeuropace

Abstract The aim of this survey was to provide insight into current practice regarding the use of antiarrhythmic drugs for atrial fibrillation (AF) among members of the European Heart Rhythm ...

Europace, EP Wire, Nikolaos Dagres, Thorsten Lewalter, Gregory Y. H. Lip, Laurent Pison, Alessandro Proclemer, Carina Blomström-Lundqvist, conducted by the Scientific Initiatives Committee, ...

Date : 01/04/2013 Item size : 154992 bytes
Epeuropace

Abstract Aim Changes in ventricular refractoriness and repolarization after successful electrical cardioversion to sinus rhythm in persistent atrial fibrillation (AF) patients were studied. Methods ...

Europace, Regular Article, Emmanuel G. Manios, Eleftherios M. Kallergis, Emmanuel M. Kanoupakis, Hercules E. Mavrakis, Helen K. Mouloudi, Nikolaos K. Klapsinos, Panos E. Vardas

Date : 01/01/2005
Epeuropace

Outcome of pharmacological rhythm control for new-onset persistent atrial fibrillation in patients with systolic heart failure: a comparison with patients with normal left ventricular ...

Europace, ANTIARRHYTHMIC DRUGS, Martin E.W. Hemels, Ans C.P. Wiesfeld, Dirk J. Van Veldhuisen, Maarten P. Van den Berg, Isabelle C. Van Gelder

Date : 01/04/2007
Epeuropace

Results Centre characteristics Responses were received from 57 centres participating in the EHRA EP research network over a wide geographical area. Activity, equipment, and technique of ...

Europace, EP WIRE, Antonio Hernández-Madrid, Jesper Hastrup Svendsen, Gregory Y.H. Lip, Isabelle C. Van Gelder, Dan Dobreanu, Carina Blomstrom-Lundqvist, conducted by the Scientific Initiatives ...

Date : 01/06/2013
Epeuropace

The PREFER in atrial fibrillation (AF) registry (PREvention oF thromboembolic eventsEuropean Registry in Atrial Fibrillation) is published in this issue of EP Europace by Kirchhof et al.1 It concerns ...

Europace, Editorial, Irene Savelieva, A. John Camm

Date : 01/01/2014
Epeuropace

Preamble It is important that the medical profession play a significant role in critically evaluating the use of diagnostic procedures and therapies as they are introduced and tested in the ...

Europace, ACC/AHA/ESC GUIDELINES, Valentin Fuster, Lars E. Rydén, David S. Cannom, Harry J. Crijns, Anne B. Curtis, Kenneth A. Ellenbogen, Jonathan L. Halperin, Jean-Yves Le Heuzey, G. Neal Kay, ...

Date : 01/09/2006
Epeuropace

Clinical trials comparing rate control with rhythm control Randomized trials comparing outcomes of rhythm vs. rate control strategies in patients with AF are summarized in Tables 13 and 14.8692 Among ...

Europace, ESC GUIDELINES, Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), ...

Date : 01/10/2010